學術產出-Theses

Article View/Open

Publication Export

Google ScholarTM

政大圖書館

Citation Infomation

  • No doi shows Citation Infomation
題名 對多重利益相關者之意義提升是臨床醫療服務典範轉移的原因—以某區域教學醫院主動脈瘤支架手術迅速普及之經驗為例
Newly defined meanings to multiple stakeholders are the reasons for paradigm shift in clinical medical service— experience from the rapid adoption of endovascular aortic repair in a regional hospital
作者 諶大中
Shen, Ta Chung
貢獻者 苑守慈
諶大中
Shen, Ta Chung
關鍵詞 腹主動脈瘤
主動脈腔內修復
創新
典範轉移
意義
臨床醫療服務
abdominal aortic aneurysm
endovascular aortic repair
innovation
paradigm shift
meaning
clinical medical service
日期 2010
上傳時間 5-Oct-2011 14:33:45 (UTC+8)
摘要 在現代外科實務中,我們今天認為是標準作業程序的手術,追溯到初期可能是激進創新。多年來,外科技術雖然已經有頻繁的修改,但往往是漸進式地。心臟和血管外科領域中的大多數創新並沒有導致日常實踐劇變。然而,在過去的幾年中,在我服務的醫院和全世界,我看到了治療腹主動脈瘤 (AAA) 的典範轉移,亦即主動脈腔內修復 (EVAR)。
相對於傳統開腹手術修復 (OSR),主動脈腔內修復較傳統開腹手術修復有顯著較低的手術死亡率。不過,長遠來說,總死亡率或動脈瘤相關死亡率並無差異;而主動脈腔內修復有較高的植入物相關併發症和必須再次手術的機率,且成本更高。然而,主動脈腔內修復還是成為腹主動脈瘤治療的支柱。這是為什麼?
除了是激進的技術創新,主動脈腔內修復也是技術頓悟。傳統上,醫療服務是典型的技術輔助服務情境,其中包含兩個單獨的、然而是密切相關的溝通系統: 一個是產業與醫師之間,另一個是醫師與病人之間。醫師居於樞紐地位,不僅確保治療之執行,而且還要評估結果。由於現代資訊與通信技術的發達,病人可以方便地搜尋輔助醫療文獻資訊、線上資訊和個人社會網絡的意見。這就像是詮釋者的作用。這詮釋者的解釋對病人、外科醫生、和醫療產業界產生了實質上重大的影響,反之亦然。以前在這服務體系中互相分離的部分現在可以緊密地互相配合了,這與服務導向邏輯中價值共同創造的概念是不謀而合的。
總之,對多重利益相關者之意義提升是臨床醫療服務典範轉移的原因。在醫療行業中引入服務導向邏輯的概念的重要性,不論是在日常實務和創新策略上的意義都是不容忽視的。醫療服務中,多重利益相關者比以前更涉及共同創造價值的過程。未來的創新者除了專注在技術和科技上,更必須考慮該創新對多重利益相關者之意義提升。
In modern surgical practice, what we consider as standard procedures today may be radical innovations dated back to the early days. Over the years, there has been frequent modification of surgical techniques, often incremental though, and most innovations in the field of cardiac and vascular surgery didn’t result in drastic changes in the daily practice. However, during the past several years, I have been witnessing a paradigm shift in the treatment of abdominal aortic aneurysm (AAA) in my hospital and worldwide towards endovascular aortic repair (EVAR).
In comparison to the traditional open surgical repair (OSR), EVAR was associated with a significantly lower operative mortality than OSR. However, no differences were seen in total mortality or aneurysm-related mortality in the long term, and EVAR was associated with increased rates of graft-related complications and reinterventions and was more costly. Nevertheless, EVAR is becoming the mainstay of AAA treatment. Why is this?
Except for being a radical technology innovation, EVAR is also a technology epiphany. Traditionally, medical service is a typical technology-assisted service encounter, consisting of two separate, however, closely inter-related communication systems: one between the industry and the physician, and the other one between the physician and the patient. The physician is of the pivot role that not only ensures the execution of treatment but also evaluates the results.With modern information and communication technologies, patients caneasily search information from paramedical literatures, online information, and opinions from personal social network. This serves the emerging role of an interpretor. This interpretors’interpretation has substantial influence on patients, surgeons, industry, and payers and vice versa. Previously separated parts in the service system now can be closely inter-related. This is in concordance with the concept of co-creation of value in service-dominant logic.
It is concluded that newly defined meanings to multiple stakeholders are the reasons for paradigm shift in clinical medical service. The importance of introduction of the concept of service-dominant logic into the medical industry, both in daily practice and in innovation strategy can never be over-emphasized. Multiple stakeholders are being involved much more than before in the process of co-creation of value in medical service.Future innovators must concentrate on meanings to multiple stakeholders as well on techniques and technologies.
參考文獻 References:
1. 王嵩竑,徐純慧,謝錦堂「臺灣醫療產業創新策略之研究」,第三屆創新與創造力研討會論文,2005年。
2. Albuquerque, F.C. Jr., Tonnessen, B.H., Noll, R.E. Jr., Cires, G., Kim, J.K., &Sternbergh, W.C. 3rd. (2010). Paradigm shifts in the treatment of abdominal aortic aneurysm: trends in 721 patients between 1996 and 2008.J Vasc Surg 2010;51:1348-52; discussion 1352-3.
3. Blackhouse, G., Hopkins, R., Bowen, J. M., De Rose, G., Novick, T., Tarride, J. E., & et al. (2009). A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada.Value Health2009;12:245-52.
4. Brewster, D. C., Cronenwett, J. L., Hallett, J. W. Jr., Johnston, K. W., Krupski, W. C., &Matsumura, J. S. (2003). Guidelinesfor the treatment of abdominal aortic aneurysms. Report ofa subcommittee of the Joint Council of the American Associationfor Vascular Surgery and Society for Vascular Surgery.J Vasc Surg 2003;37:1106-1117.
5. Chambers, D., Epstein, D., Walker, S., Fayter, D., Paton, F., Wright, K.,& et al. (2009). Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.Health Technol Assess 2009;13:1-189, 215-318.
6. Chao, Y. C. “Words from the Superintendent.” available at: http://www.tzuchi.com.tw/tzuchi_en/About_TP_Center/Default.htm (retrieved June 13, 2011)
7. Charles, C., Gafni, A., &Whelan, T. (1997). "Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)". Soc Sci Med 44 (5): 681–92.
8. Criado, F. J. (2010). EVAR at 20: the unfolding of a revolutionary new technique that changed everything. J ENDOVASC THER2010;17:789–796.
9. Danjoux, N. M., Martin, D. K., Lehoux, P. N., Harnish, J. L., Shaul, R. Z., Berstein, M., & et al. (2007). Adoption of an innovation to repair aortic aneurysms at a Canadianhospital: a qualitative case study and evaluation. BMC Health Services Research 2007, 7:182.
10. Delong, T. J., Gabarro, J. J., &Lees, R. J. (2007). “The High-Need-for- Achievement Personality. Motivating, Retaining, and Developing Your Talent.” When Professionals Have to Lead. Harvard Business School Press 2007.
11. EVAR participants. (2005). Endovascular aneurysm repair versus open repair in patientswith abdominal aortic aneurysm (EVAR trial 1): Randomisedcontrolled trial.Lancet 365:2179-2186, 2005.
12. Gloviczki, P., &Ricotta, J. J. (2011). “Aneurysmal Vascular Disease:” Sabiston Textbook of Surgery, 18th Edition. Elsevier 2011.
13. Goldberg, C.G., Berman, L.,& Gusberg, R.J. (2010). Limitations of online information on abdominal aortic aneurysm. Int J Vasc Med2010;2010:789198.
14. Levinson, W., Kao, A., Kuby, A., &Thisted, R .A. (2005). Not all patients want to participate in decision making. anational study of public preferences. J Gen Intern Med 2005;20:531-5.
15. Moller, J.H., Shumway, S.J.,& Gott, V.L. (2009). The first open-heart repairs using extracorporeal circulation by cross-circulation: a 53-year follow-up.Ann Thorac Surg. 2009;88:1044-6.
16. Parodi. J. C. (1997). Endoluminal treatment of arterial diseases using a stent-graft combination: reflections 20 years after the initial concept. J Endovasc Surg 1997;4:3-4.
17. Parodi, J. C., Palmaz, J. C., &Barone, H. D. (1991). Transfemoral intraluminalgraft implantation for abdominal aortic aneurysms. AnnVasc Surg 1991;5:491-499.
18. President`s Advisory Commission on Consumer Protection and Quality in the Health Care Industry (1998). "Quality First: Better Health Care for All Americans". http://www.hcqualitycommission.gov/final.
19. Rutherford, R .B. (2006). Randomized EVAR trials and advent of level 1 evidence: a paradigm shift in management of large abdominal aortic aneurysms?Semin Vasc Surg. 2006;19:69-74.
20. Rutherford, R .B., &Krupski, W. C. (2004). Current status of open versusendovascular stent-graft repair of abdominal aortic aneurysm.J Vasc Surg 2004;39:1129-1139.
21. Salzburg Global Seminar. (2011). Salzburg statement on shared decision making. BMJ 2011;22;342.
22. Seelig, M. H., Oldenburg, W. A., Hakaim, A. G., Hallett, J. W., Chowla, A., Andrews, J. C.,& et al. (1999). Endovascular repair of abdominal aortic aneurysms: where do we stand?Mayo Clin Proc 1999;74:999-1010.
23. Tarride, J. E., Blackhouse, G., De Rose, G., Novick, T., Bowen, J. M., Hopkins, R., & et al. (2008). Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada.J Vasc Surg 2008;48:779-87.
24. United Kingdom EVAR Trial Investigators, Greenhalgh, R. M., Brown, L. C., Powell, J. T., Thompson, S. G., Epstein, D.,&Sculpher, M. J. (2010). Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362:1863-71.
25. United Kingdom EVAR Trial Investigators, Greenhalgh, R.M., Brown, L.C., Powell, J.T., Thompson, S.G., Epstein, D., &Sculpher, M.J. (2010). Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med 2010;362:1872-80.
26. Vargo, S. L., & Lusch, R. F. (2004). Evolving to a new dominantlogic for marketing.Journal of Marketing, 68, 1–17.
27. Vargo, S. L., & Lusch, R. F. (2008).Service-dominant logic: continuing the evolution. J. of the Acad. Mark. Sci. (2008) 36:1–10.
28. Verganti, R. (2008). Design, meanings, and radical innovation: ametamodel and a research agenda. J PROD INNOV MANAG2008;25:436–456.
29. Young, K. C., Awad, N. A., Johansson, M., Gillespie, D., Singh, M. J.,& Illig, K. A. (2010). Cost-effectiveness of abdominal aortic aneurysm repair based on aneurysm size.J Vasc Surg 2010;51:27-32; discussion 32.
30. Zarins, C. K.& Harris E., J. (1997). Operative repair for aortic aneurysms: the gold standard. J Endovasc Surg 1997;4:232-241.
31. Zarins, C. K. & Taylor, C. A. (2009). Endovascular device design in the future:Transformation from trial and error to computational design. J EndovascTher 2009;16(Suppl I):I12–I21.
描述 碩士
國立政治大學
經營管理碩士學程(EMBA)
97932095
99
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0097932095
資料類型 thesis
dc.contributor.advisor 苑守慈zh_TW
dc.contributor.author (Authors) 諶大中zh_TW
dc.contributor.author (Authors) Shen, Ta Chungen_US
dc.creator (作者) 諶大中zh_TW
dc.creator (作者) Shen, Ta Chungen_US
dc.date (日期) 2010en_US
dc.date.accessioned 5-Oct-2011 14:33:45 (UTC+8)-
dc.date.available 5-Oct-2011 14:33:45 (UTC+8)-
dc.date.issued (上傳時間) 5-Oct-2011 14:33:45 (UTC+8)-
dc.identifier (Other Identifiers) G0097932095en_US
dc.identifier.uri (URI) http://nccur.lib.nccu.edu.tw/handle/140.119/51226-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 經營管理碩士學程(EMBA)zh_TW
dc.description (描述) 97932095zh_TW
dc.description (描述) 99zh_TW
dc.description.abstract (摘要) 在現代外科實務中,我們今天認為是標準作業程序的手術,追溯到初期可能是激進創新。多年來,外科技術雖然已經有頻繁的修改,但往往是漸進式地。心臟和血管外科領域中的大多數創新並沒有導致日常實踐劇變。然而,在過去的幾年中,在我服務的醫院和全世界,我看到了治療腹主動脈瘤 (AAA) 的典範轉移,亦即主動脈腔內修復 (EVAR)。
相對於傳統開腹手術修復 (OSR),主動脈腔內修復較傳統開腹手術修復有顯著較低的手術死亡率。不過,長遠來說,總死亡率或動脈瘤相關死亡率並無差異;而主動脈腔內修復有較高的植入物相關併發症和必須再次手術的機率,且成本更高。然而,主動脈腔內修復還是成為腹主動脈瘤治療的支柱。這是為什麼?
除了是激進的技術創新,主動脈腔內修復也是技術頓悟。傳統上,醫療服務是典型的技術輔助服務情境,其中包含兩個單獨的、然而是密切相關的溝通系統: 一個是產業與醫師之間,另一個是醫師與病人之間。醫師居於樞紐地位,不僅確保治療之執行,而且還要評估結果。由於現代資訊與通信技術的發達,病人可以方便地搜尋輔助醫療文獻資訊、線上資訊和個人社會網絡的意見。這就像是詮釋者的作用。這詮釋者的解釋對病人、外科醫生、和醫療產業界產生了實質上重大的影響,反之亦然。以前在這服務體系中互相分離的部分現在可以緊密地互相配合了,這與服務導向邏輯中價值共同創造的概念是不謀而合的。
總之,對多重利益相關者之意義提升是臨床醫療服務典範轉移的原因。在醫療行業中引入服務導向邏輯的概念的重要性,不論是在日常實務和創新策略上的意義都是不容忽視的。醫療服務中,多重利益相關者比以前更涉及共同創造價值的過程。未來的創新者除了專注在技術和科技上,更必須考慮該創新對多重利益相關者之意義提升。
zh_TW
dc.description.abstract (摘要) In modern surgical practice, what we consider as standard procedures today may be radical innovations dated back to the early days. Over the years, there has been frequent modification of surgical techniques, often incremental though, and most innovations in the field of cardiac and vascular surgery didn’t result in drastic changes in the daily practice. However, during the past several years, I have been witnessing a paradigm shift in the treatment of abdominal aortic aneurysm (AAA) in my hospital and worldwide towards endovascular aortic repair (EVAR).
In comparison to the traditional open surgical repair (OSR), EVAR was associated with a significantly lower operative mortality than OSR. However, no differences were seen in total mortality or aneurysm-related mortality in the long term, and EVAR was associated with increased rates of graft-related complications and reinterventions and was more costly. Nevertheless, EVAR is becoming the mainstay of AAA treatment. Why is this?
Except for being a radical technology innovation, EVAR is also a technology epiphany. Traditionally, medical service is a typical technology-assisted service encounter, consisting of two separate, however, closely inter-related communication systems: one between the industry and the physician, and the other one between the physician and the patient. The physician is of the pivot role that not only ensures the execution of treatment but also evaluates the results.With modern information and communication technologies, patients caneasily search information from paramedical literatures, online information, and opinions from personal social network. This serves the emerging role of an interpretor. This interpretors’interpretation has substantial influence on patients, surgeons, industry, and payers and vice versa. Previously separated parts in the service system now can be closely inter-related. This is in concordance with the concept of co-creation of value in service-dominant logic.
It is concluded that newly defined meanings to multiple stakeholders are the reasons for paradigm shift in clinical medical service. The importance of introduction of the concept of service-dominant logic into the medical industry, both in daily practice and in innovation strategy can never be over-emphasized. Multiple stakeholders are being involved much more than before in the process of co-creation of value in medical service.Future innovators must concentrate on meanings to multiple stakeholders as well on techniques and technologies.
en_US
dc.description.tableofcontents Title page 1
Dedication 2
Acknowledgement 3
Abstract (Chinese) 4
Abstract 5
List of tables 9
List of figures 10
Chapter I Introduction 11
1.1 Motivation of the Study 11
1.2 Research Objectives and Questions 12
1.3 Research Flow and Chapter Description 12
1.4 Research Scope and Limitation 13
Chapter IIReview of Literature 14
2.1 Abdominal Aortic Aneurysm (AAA) 14
2.1.1 Introduction of Abdominal Aortic Aneurysm 14
2.1.2 Open Surgical Repair (OSR) 17 2.1.3 Endovascular Aortic Repair (EVAR) 19
2.2 Evaluation of Different Treatment Modalities 21
2.2.1 Clinical Results of Different Treatment Modalities 21
2.2.2 Cost-effectiveness of Different Treatment Modalities 25 2.3 Factors Influencing Choice of Treatment 26
2.3.1 Shared Decision Making Model 26
2.3.2 Impact of Online Information on Decision Making 28 2.3.3 Service-dominant Logic and Co-creation of Value 30
2.4 Innovation— the EVAR Experience and Design-Driven Innovation 33
2.4.1 History of EarlyInnovation and Development of EVAR 33
2.4.2 Future Perspective of Technological Innovation in EVAR 34 2.4.3 Technology Epiphany: the Interplay between Technology Push and Design-Driven Innovation 35
2.5 Dissemination of Medical Innovation 37
2.5.1 History of Development of EVAR 37
2.5.2 Adoption of EVAR 39
2.6 Summary of Literature Review 40 2.6.1 Abdominal aortic aneurysm is a serious disease. 40
2.6.2 Endovascular aortic repair is becoming the mainstream of AAA treatment. 40
2.6.3 EVAR is not as cost-effective as we expect. 41
2.6.4 Patient participation should be encouraged and facilitated to co-create value. 41
2.6.5 EVAR Is a Technology Epiphany? 43
Chapter IIIResearch Methodology 45
3.1 Research Methodology 45
3.1.1 Research Design and Interview Guidelines 45
3.1.2 Information Collection 46
Chapter IVCase Description and Analysis 48
4.1 Current Features of Medical Service in Taiwan 48
4.2 Current Status and Strategy of the Case Hospital 49
4.3 Endovascular Aortic Repair (EVAR) in the Case Hospital 52
4.3.1 Introduction of EVAR into the Department of Cardiovascular Surgery 52
4.3.2 Conduct of EVAR in Regional Hospitals (including the case hospital) in Taiwan 53 4.4 Paradigm shift in surgical treatment of abdominal aortic aneurysm 56
4.5 Analysis of In-depth Review 58
4.6 Decision Making Process 61
Chapter VResearch findings 62
5.1 Reasons for Paradigm Shift 62
5.1.1 Newly Defined Meanings to Multiple Stakeholders Are the Reasons for Paradigm Shift in Clinical Medical Service — Patient Perspective 62
5.1.2 Newly Defined Meanings to Multiple Stakeholders Are the Reasons for Paradigm Shift in Clinical Medical Service — Provider Perspective 64
5.2 Innovation Model in the Transformation Process from Traditional Open Surgery to Modern Less Invasive Surgery 66
Chapter VI Conclusions and Future Perspectives 69
References: 72
zh_TW
dc.language.iso en_US-
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0097932095en_US
dc.subject (關鍵詞) 腹主動脈瘤zh_TW
dc.subject (關鍵詞) 主動脈腔內修復zh_TW
dc.subject (關鍵詞) 創新zh_TW
dc.subject (關鍵詞) 典範轉移zh_TW
dc.subject (關鍵詞) 意義zh_TW
dc.subject (關鍵詞) 臨床醫療服務zh_TW
dc.subject (關鍵詞) abdominal aortic aneurysmen_US
dc.subject (關鍵詞) endovascular aortic repairen_US
dc.subject (關鍵詞) innovationen_US
dc.subject (關鍵詞) paradigm shiften_US
dc.subject (關鍵詞) meaningen_US
dc.subject (關鍵詞) clinical medical serviceen_US
dc.title (題名) 對多重利益相關者之意義提升是臨床醫療服務典範轉移的原因—以某區域教學醫院主動脈瘤支架手術迅速普及之經驗為例zh_TW
dc.title (題名) Newly defined meanings to multiple stakeholders are the reasons for paradigm shift in clinical medical service— experience from the rapid adoption of endovascular aortic repair in a regional hospitalen_US
dc.type (資料類型) thesisen
dc.relation.reference (參考文獻) References:zh_TW
dc.relation.reference (參考文獻) 1. 王嵩竑,徐純慧,謝錦堂「臺灣醫療產業創新策略之研究」,第三屆創新與創造力研討會論文,2005年。zh_TW
dc.relation.reference (參考文獻) 2. Albuquerque, F.C. Jr., Tonnessen, B.H., Noll, R.E. Jr., Cires, G., Kim, J.K., &Sternbergh, W.C. 3rd. (2010). Paradigm shifts in the treatment of abdominal aortic aneurysm: trends in 721 patients between 1996 and 2008.J Vasc Surg 2010;51:1348-52; discussion 1352-3.zh_TW
dc.relation.reference (參考文獻) 3. Blackhouse, G., Hopkins, R., Bowen, J. M., De Rose, G., Novick, T., Tarride, J. E., & et al. (2009). A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada.Value Health2009;12:245-52.zh_TW
dc.relation.reference (參考文獻) 4. Brewster, D. C., Cronenwett, J. L., Hallett, J. W. Jr., Johnston, K. W., Krupski, W. C., &Matsumura, J. S. (2003). Guidelinesfor the treatment of abdominal aortic aneurysms. Report ofa subcommittee of the Joint Council of the American Associationfor Vascular Surgery and Society for Vascular Surgery.J Vasc Surg 2003;37:1106-1117.zh_TW
dc.relation.reference (參考文獻) 5. Chambers, D., Epstein, D., Walker, S., Fayter, D., Paton, F., Wright, K.,& et al. (2009). Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model.Health Technol Assess 2009;13:1-189, 215-318.zh_TW
dc.relation.reference (參考文獻) 6. Chao, Y. C. “Words from the Superintendent.” available at: http://www.tzuchi.com.tw/tzuchi_en/About_TP_Center/Default.htm (retrieved June 13, 2011)zh_TW
dc.relation.reference (參考文獻) 7. Charles, C., Gafni, A., &Whelan, T. (1997). "Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango)". Soc Sci Med 44 (5): 681–92.zh_TW
dc.relation.reference (參考文獻) 8. Criado, F. J. (2010). EVAR at 20: the unfolding of a revolutionary new technique that changed everything. J ENDOVASC THER2010;17:789–796.zh_TW
dc.relation.reference (參考文獻) 9. Danjoux, N. M., Martin, D. K., Lehoux, P. N., Harnish, J. L., Shaul, R. Z., Berstein, M., & et al. (2007). Adoption of an innovation to repair aortic aneurysms at a Canadianhospital: a qualitative case study and evaluation. BMC Health Services Research 2007, 7:182.zh_TW
dc.relation.reference (參考文獻) 10. Delong, T. J., Gabarro, J. J., &Lees, R. J. (2007). “The High-Need-for- Achievement Personality. Motivating, Retaining, and Developing Your Talent.” When Professionals Have to Lead. Harvard Business School Press 2007.zh_TW
dc.relation.reference (參考文獻) 11. EVAR participants. (2005). Endovascular aneurysm repair versus open repair in patientswith abdominal aortic aneurysm (EVAR trial 1): Randomisedcontrolled trial.Lancet 365:2179-2186, 2005.zh_TW
dc.relation.reference (參考文獻) 12. Gloviczki, P., &Ricotta, J. J. (2011). “Aneurysmal Vascular Disease:” Sabiston Textbook of Surgery, 18th Edition. Elsevier 2011.zh_TW
dc.relation.reference (參考文獻) 13. Goldberg, C.G., Berman, L.,& Gusberg, R.J. (2010). Limitations of online information on abdominal aortic aneurysm. Int J Vasc Med2010;2010:789198.zh_TW
dc.relation.reference (參考文獻) 14. Levinson, W., Kao, A., Kuby, A., &Thisted, R .A. (2005). Not all patients want to participate in decision making. anational study of public preferences. J Gen Intern Med 2005;20:531-5.zh_TW
dc.relation.reference (參考文獻) 15. Moller, J.H., Shumway, S.J.,& Gott, V.L. (2009). The first open-heart repairs using extracorporeal circulation by cross-circulation: a 53-year follow-up.Ann Thorac Surg. 2009;88:1044-6.zh_TW
dc.relation.reference (參考文獻) 16. Parodi. J. C. (1997). Endoluminal treatment of arterial diseases using a stent-graft combination: reflections 20 years after the initial concept. J Endovasc Surg 1997;4:3-4.zh_TW
dc.relation.reference (參考文獻) 17. Parodi, J. C., Palmaz, J. C., &Barone, H. D. (1991). Transfemoral intraluminalgraft implantation for abdominal aortic aneurysms. AnnVasc Surg 1991;5:491-499.zh_TW
dc.relation.reference (參考文獻) 18. President`s Advisory Commission on Consumer Protection and Quality in the Health Care Industry (1998). "Quality First: Better Health Care for All Americans". http://www.hcqualitycommission.gov/final.zh_TW
dc.relation.reference (參考文獻) 19. Rutherford, R .B. (2006). Randomized EVAR trials and advent of level 1 evidence: a paradigm shift in management of large abdominal aortic aneurysms?Semin Vasc Surg. 2006;19:69-74.zh_TW
dc.relation.reference (參考文獻) 20. Rutherford, R .B., &Krupski, W. C. (2004). Current status of open versusendovascular stent-graft repair of abdominal aortic aneurysm.J Vasc Surg 2004;39:1129-1139.zh_TW
dc.relation.reference (參考文獻) 21. Salzburg Global Seminar. (2011). Salzburg statement on shared decision making. BMJ 2011;22;342.zh_TW
dc.relation.reference (參考文獻) 22. Seelig, M. H., Oldenburg, W. A., Hakaim, A. G., Hallett, J. W., Chowla, A., Andrews, J. C.,& et al. (1999). Endovascular repair of abdominal aortic aneurysms: where do we stand?Mayo Clin Proc 1999;74:999-1010.zh_TW
dc.relation.reference (參考文獻) 23. Tarride, J. E., Blackhouse, G., De Rose, G., Novick, T., Bowen, J. M., Hopkins, R., & et al. (2008). Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada.J Vasc Surg 2008;48:779-87.zh_TW
dc.relation.reference (參考文獻) 24. United Kingdom EVAR Trial Investigators, Greenhalgh, R. M., Brown, L. C., Powell, J. T., Thompson, S. G., Epstein, D.,&Sculpher, M. J. (2010). Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010;362:1863-71.zh_TW
dc.relation.reference (參考文獻) 25. United Kingdom EVAR Trial Investigators, Greenhalgh, R.M., Brown, L.C., Powell, J.T., Thompson, S.G., Epstein, D., &Sculpher, M.J. (2010). Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med 2010;362:1872-80.zh_TW
dc.relation.reference (參考文獻) 26. Vargo, S. L., & Lusch, R. F. (2004). Evolving to a new dominantlogic for marketing.Journal of Marketing, 68, 1–17.zh_TW
dc.relation.reference (參考文獻) 27. Vargo, S. L., & Lusch, R. F. (2008).Service-dominant logic: continuing the evolution. J. of the Acad. Mark. Sci. (2008) 36:1–10.zh_TW
dc.relation.reference (參考文獻) 28. Verganti, R. (2008). Design, meanings, and radical innovation: ametamodel and a research agenda. J PROD INNOV MANAG2008;25:436–456.zh_TW
dc.relation.reference (參考文獻) 29. Young, K. C., Awad, N. A., Johansson, M., Gillespie, D., Singh, M. J.,& Illig, K. A. (2010). Cost-effectiveness of abdominal aortic aneurysm repair based on aneurysm size.J Vasc Surg 2010;51:27-32; discussion 32.zh_TW
dc.relation.reference (參考文獻) 30. Zarins, C. K.& Harris E., J. (1997). Operative repair for aortic aneurysms: the gold standard. J Endovasc Surg 1997;4:232-241.zh_TW
dc.relation.reference (參考文獻) 31. Zarins, C. K. & Taylor, C. A. (2009). Endovascular device design in the future:Transformation from trial and error to computational design. J EndovascTher 2009;16(Suppl I):I12–I21.zh_TW